Abstract | BACKGROUND: METHODS: RESULTS: There was no significant difference in the baseline characteristics between the two groups. The cTFC parameter in Group A was significantly lower than Group B (18.06 ± 2.06 vs. 25.31 ± 2.59, P < 0.01). The ratio of final MBG grade-3 was significantly higher (P < 0.05) in Group A (87.9%) relative to Group B (65.7%). There was no significant difference between the two groups in final TIMI-3 flow and no-reflow. Patients were followed up for 6 months, and the occurrence of MACE in Group A was significantly lower than that in Group B (6.1% vs. 25.9% respectively, P < 0.05). CONCLUSIONS:
|
Authors | Li-Ye Wei, Xiang-Hua Fu, Wei Li, Xi-Le Bi, Shi-Ru Bai, Kun Xing, Yan-Bo Wang |
Journal | Chinese medical journal
(Chin Med J (Engl))
Vol. 128
Issue 9
Pg. 1147-50
(May 05 2015)
ISSN: 2542-5641 [Electronic] China |
PMID | 25947394
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
|
Topics |
- Administration, Intravenous
- Aged
- Alprostadil
(administration & dosage, therapeutic use)
- Female
- Humans
- Male
- Microcirculation
(drug effects)
- Middle Aged
- Myocardial Infarction
(drug therapy)
- Percutaneous Coronary Intervention
(methods)
|